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IGF-I receptors were partially purified from red and white skeletal muscle by lectin-affinity chromatography and the re- 
sultant fraction was depleted of insulin receptors by insulin affinity chromatography. Equilibrium binding of ‘ZSI-IGF-I 
to receptor preparations from red and white muscle yielded identical Scatchard plots. The integrity of the IGF-I receptor 
preparation in the two fiber types was identical as determined by affinity cross-linking. The tyrosine kinase activity of 
the receptor from red muscle was 2-3-fold more active towards exogenous substrates in both the basal and ligand-activat- 
ed states as compared to white muscle. These data show that there is IGF-I-dependent kinase activity intrinsic to IGF-I 
receptors from skeletal muscle, and suggest that identical cellular factors may regulate the kinase activity of insulin and 
IGF-I receptors in a parallel manner in vivo. 
IGF-I receptor; Tyrosine kinase; (Skeletal muscle, Rat) 
1. INTRODUCTION 
Insulin-like growth factor I (IGF-I) belongs to a 
family of peptides structurally related to insulin. In 
muscle and in cultured cell lines, IGF-I causes a 
variety of cellular metabolic changes including 
stimulation of glucose and amino acid uptake, and 
glycogen and protein synthesis [l-3]. These 
biological effects are initiated after binding to 
specific cell surface receptors. The receptor for 
IGF-I, like the closely related insulin receptor, is a 
tetrameric glycoprotein complex consisting of two 
ligand-binding a-subunits and two ,8-subunits 
linked by disulfide bonds [4,5]. The &subunits of 
the insulin [6] and IGF-I [7,8] receptors are ligand- 
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stimulatable, tyrosine-specific protein kinases. 
There is a considerable amount of indirect 
evidence to suggest that the intrinsic kinase activity 
of these receptors may be involved in signalling, 
however, the biochemical pathway of this process 
remains to be described. 
We recently reported that quantitative dif- 
ferences in insulin action in red vs white muscle are 
mirrored by intrinsic differences in the kinase ac- 
tivity of the insulin receptor in the two muscle 
types [9]. Here, we have examined the kinase ac- 
tivity of the IGF-I receptor in red and white 
muscle. 
2. MATERIALS AND METHODS 
2.1. Preparation of partially purified receptors 
Male Sprague-Dawley rats (Charles River, Wilmington, MA) 
weighing 250-300 g and fed ad libitum were used for all 
studies. Hindlimb muscle was obtained from sodium pentobar- 
bital anesthetized rats and frozen in liquid Nz as in 191. In ex- 
periments on red and white muscle, red muscle consisted of 
pooled soleus, red portions of the gastrocnemius and 
quadriceps muscles. White portions of the gastrocnemius and 
Published by Ekevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 257 
Volume 234, number 2 FEBS LETTERS July 1988 
quadriceps were pooled as the source of white muscle. Frozen 
muscle was powdered, homogenized and solubilized in 1% 
Triton X-100 as described 191. The solubilized homogenate was 
centrifuged at 150000 x g for 90 min at 4°C. The supernatant 
of the centrifugation was applied to a column of wheat germ ag- 
glutinin bound to agarose (WGA) and receptors were eluted 
from the WGA column with a buffer containing 25 mM Hepes, 
0.1% Triton X-100 and 0.3 M N-acetyl-D-glucosamine. In 
order to separate IGF-I receptors from insulin receptors present 
in the WGA eluate, samples were subjected to insulin-affinity 
chromatography. Typically, a receptor preparation (2 ml) con- 
taining 0.5 M NaCl was recycled overnight at 4”C, through an 
insulin-affinity column (3 ml resin bed) at a rate of 30 ml/h and 
the flow-through was collected the next morning. The flow- 
through, which was depleted in insulin receptors, was then 
dialyzed extensively for 12 h at 4°C against 1000 vols of a buf- 
fer containing 25 mM Hepes, 0.1% Triton X-100, pH 7.4. The 
preparation was reconcentrated using WGA chromatography. 
Receptors were then eluted with a buffer containing 25 mM 
Hepes, 0.1% Triton X-100, 0.3 M N-acetyl-D-glucosamine. 
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Fig. 1. IGF-I- and insulin-stimulated phosphorylation of an exogenous substrate. Preparations obtained before (A) or after (B) partial 
depletion of insulin receptors by the insulin affinity step (30 ~1) were incubated for 1 h at 22°C with varying concentrations of insulin 
(+) or IGF-I (0) in 30 mM Hepes buffer, pH 7.6, and 10 mM MgC12. Samples were further incubated with 50,~M [y-“P]ATP 
(5-10,&i) for 10 min and then the reaction was initiated by the addition of the substrate (copolymer of Glu/Tyr). Each data point 
is the mean of duplicate estimations and the results shown are representative of three different experiments. 
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2.2. Ligand binding and receptor cross-linking 
Insulin and IGF-I binding was measured as in [9]. Sample 
eluate (20 ~1) was incubated in 50 mM Hepes containing 0.1 Vo 
BSA and 100 U/ml bacitracin (pH 7.4, 1 h, 22”C, 200 ,ul) and 
either ?-Tyr Al4 monoiodoinsulin (50 pM, 20000 cpm) and 
increasing concentrations of unlabelled insulin or ‘251-IGF-I 
(50 pM, 35000 cpm) and increasing concentrations of unla- 
belled IGF-I. Non-specific binding was estimated as ‘Z51-ligand 
bound in the presence of 1 gM insulin or 0.25 pM IGF-I 
(5-10% of total insulin binding and 12-18% of total IGF-I 
binding). Binding data were expressed per pg protein with the 
latter measured using the method of Bradford [lo]. Receptor 
cross-linking protocols were carried out essentially as described 
by Pilch and Czech [ll] using 0.5 nM ‘ZSI-IGF-I. 
2.3. Phosphorylation of an exogenous ubstrate 
To assess phosphorylation of an exogenous substrate, the 
partially purified receptor preparation was preincubated for 1 h 
at 22°C in 30 mM Hepes buffer, pH 7.6, containing 10 mM 
MgClz and varying concentrations of insulin or IGF-I. The 
receptor kinase activity was initially activated by the addition of 
50 gM [y-32P]ATP (5-10 pCi) for 10 min. The reaction was in- 
itiated by the addition of the exogenous substrate (copolymer of 
Glu/Tyr, 0.25 mg/ml). The reaction was stopped after 30 min 
by applying samples to filter paper squares (2 x 2 cm, What- 
mann 3 MM), which were immediately washed in 10% 
trichloroacetic acid containing 10 mM sodium pyrophosphate. 
Papers were washed, dried and counted as described [9]. 
3. RESULTS 
Scatchard analysis of 1251-IGF-I and 1251-insulin 
binding in partially purified receptor preparations 
from mixed skeletal muscle revealed the existence 
of 3-times more insulin than IGF-I receptors. The 
affinity of IGF-I for its receptor was in the 
nanomolar range (& = 1.6 nM), similar to that of 
insulin for the insulin receptor (& = 0.9 nM) (not 
shown). A partially purified receptor preparation 
obtained after lectin-affinity chromatography 
from skeletal muscle was used to assess exogenous 
kinase activity. Insulin stimulated 32P incorpora- 
tion into the copolymer GWTyr (4: 1) (fig.lA) 
and the half-maximal effect of insulin was attained 
at 1 nM. IGF-I concentrations as high as 10 nM 
failed to show any significant increase in 
copolymer phosphorylation. At 100 nM IGF-I a 
30% increase in 32P incorporation into copolymer 
was detected. It is likely that IGF-I-stimulated 
IGF-I receptor kinase activity is not demonstrable 
in the crude wheat germ agglutinin fraction due to 
masking by the more abundant insulin receptor 
kinase. Thus, insulin receptors were depleted from 
mixed receptor preparations by insulin-affinity 
chromatography. This resulted in a 60% decrease 
of insulin binding while IGF-I binding increased 
somewhat (not shown). This step did not modify 
either the affinity of the ligands for their receptors 
or the structure of the IGF-I receptors as assessed 
by affinity cross-linking (not shown). After 
removal of insulin receptors, the basal copolymer 
phosphorylation was considerably reduced, as ex- 
pected. Under these conditions IGF-I-dependent 
kinase activity was detectable at concentrations of 
IGF-I below the Kd for binding. The dose-response 
curve showed a half-maximal effect close to 1 nM, 
consistent with the Kd values for IGF-I binding 
(fig. 1B). 
This affinity-depletion technique was next 
employed to study the structure/function of the 
IGF-I receptor in red and white muscle. 
Equilibrium binding of 1251-IGF-I to partially 
purified IGF-I receptor preparations from red and 
white muscle yielded identical Scatchard plots for 
both muscle types (fig.2). IGF-I receptor number 
and affinity, calculated from three different 
Scatchard plots, were similar in red and white mus- 
cle. The molecular mass of the IGF-binding species 
present in the insulin receptor-depleted prepara- 
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Fig.2. IGF-I binding in red and white muscle. IGF-I receptors 
were partially purified from red (a) and white (0) skeletal 
muscle as described in section 2. Aliquots of purified extracts 
(20~1) were incubated for 1 h at 22°C in a buffer containing 
25 mM Hepes, 0.1 mg/ml BSA, 100 U/ml bacitracin, “‘1-IGF- 
I and varying concentrations of IGF-I. The data shown are 
from a representative Scatchard plot (n = 3). Each point is the 
mean of duplicate determinations. The results of binding 
parameters are means & SE of three observations per group. Kd 
and B,,, values are expressed as nM and fmol/pg protein, 
respectively. 
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tion of red and white muscle was determined on 
SDS-PAGE following affinity cross-linking of 
1251-IGF-I to the receptor (fig.3). Under non- 
reducing conditions two bands, specifically la- 
belled with 1251-IGF-I were detected. The 300 kDa 
band corresponds to the reported IGF-I receptor 
[5], whereas that of 220 kDa has been identified as 
the IGF-II receptor [3]. Under reducing conditions 
three different bands, that were specifically la- 
belled with 1251-IGF-I, were evident. Unlabelled 
IGF-I competed with all three bands. We interpret 
these data in the light of previous studies [ 11,121 to 
mean that the high molecular mass species that is 
not competed for by insulin is probably the IGF-II 
receptor and the other band is an LY-CY cross-linked 
complex of the IGF-I receptor, often observed 
after ‘251-insulin and 1251-IGF-I affinity cross- 
linking to their respective receptors [ 11,121. Under 
all conditions, the bands specifically labelled with 
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‘251-IGF-I did not differ between red and white 
muscle, showing that there are no gross structural 
differences in the integrity of IGF-I receptors par- 
tially purified from both fiber types. The dose- 
response relationship between IGF-I and the 32P 
incorporation into a copolymer of Glu/Tyr, in the 
presence of partially purified IGF-I receptor 
(depleted of insulin receptors) is shown in fig.4. 
Equal amounts of high-affinity IGF-I receptors, as 
estimated by equilibrium binding, were used for 
red and white muscle. IGF-I stimulated the ex- 
ogenous kinase activity of the IGF-I receptor, 
purified from red and white muscle, at all concen- 
trations examined (fig.4). These effects were 
specific for the IGF-I receptor, since increased ex- 
ogenous kinase activity was demonstrable using 
concentrations of IGF-I (1 nM) which did not 
cross-react with the insulin receptor [9]. The recep- 
tor from red muscle was 2-3-fold more active in 
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Fig.3. Affinity cross-linking of ‘ZSI-IGF-I to the IGF receptors in red and white muscle. IGF receptors purified were obtained from 
red and white muscle as described in section 2. Partially purified IGF receptors were incubated with 0.5 nM ‘*SI-IGF-I in the absence 
of unlabelled ligands (lanes A,D,G,J) or in the presence of 1 pM insulin (lanes B,E,H,K) or 0.25 ,uM IGF-I (lanes C,F,I,L) at 22°C 
for 30 min. After 5 min incubation at O”C, disuccinimidyl suberate was added at a final concentration of 1 mM, and samples were 
incubated for a further 15 min at 0°C. Affinity cross-linking reactions were terminated by addition of Laemmli sample buffer without 
(lanes A-F) or with (lanes G-L) 0.1 M dithiothreitol. 
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Fig.4. Kinase activity of IGF-I receptors from red and white 
muscle towards an exogenous substrate. Partially purified IGF- 
I receptors from red or white muscle (40 ~1) were incubated at 
22°C in 30 mM Hepes buffer, pH 7.6, containing 10 mM 
MgCls and varying concentrations of IGF-I. See details in 
legend to fig.1 and section 2. Each data point is the mean * SE 
of triplicate estimations and the results shown are representative 
of four different experiments. 
both the basal and ligand-activated states as com- 
pared to white muscle. 
4. DISCUSSION 
In this report, we provide evidence for an IGF-I- 
stimulated tyrosine kinase activity of the IGF-I 
receptor in muscle. Half-maximal phosphorylation 
of an exogenous substrate was observed in the 
vicinity of 1 nM IGF-I, which is essentially iden- 
tical to the Kd for IGF-I binding to the IGF-I 
receptor. Furthermore, we have also shown that 
IGF-I receptor kinase activity is differentially ex- 
pressed in red and white muscle. Thus, low concen- 
trations of IGF-I, such as 1 nM, caused a much 
greater stimulation of the exogenous tyrosine 
kinase activity in red than in white muscle. The dif- 
ferences were not due to alterations in the quality 
of the receptors, because studies of equilibrium 
binding and affinity cross-linking showed that the 
structural integrity of the IGF-I receptors was 
identical in red and white muscle. These results, 
together with the previous report from our 
laboratory describing the existence of similar dif- 
ferences in the activation of the insulin receptor 
kinase in red and white muscle [9], support the ex- 
istence of common regulatory mechanisms for 
both insulin and IGF-I receptors in muscle. 
However, the molecular mechanisms that are 
responsible for these differences and the cellular 
factors involved remain to be determined. 
There is a growing body of evidence indicating 
that activation of insulin receptor kinase is the in- 
itial signal that regulates some or all of the 
biological responses to this hormone. The insulin 
and IGF-I receptors have many similarities in the 
expression and regulation of their intrinsic kinase 
activities [ 13,141. In view of this and of the marked 
similarities in the biological effects of insulin and 
IGF-I [l--3], it seems quite likely that as with in- 
sulin, the intrinsic kinase activity of its receptor 
will be crucial in initiating the cellular action of 
IGF-I. However, definite proof is still lacking. 
Both insulin and IGF-I receptor kinases showed 
the same pattern of differences when comparing 
red vs w.hite muscle. Thus, the existence of com- 
mon, as yet unknown, regulatory mechanisms, 
could be envisaged. These receptors are expressed 
from different genes on different chromosomes 
[15], therefore the most likely regulatory 
mechanism is one involving a cellular component 
that would effect both receptors in a similar 
fashion, e.g. a covalent modification. In this 
regard, it is noteworthy that the insulin receptor 
kinase can be modulated by several other protein 
kinases. Cyclic AMP-dependent protein kinase 
phosphorylates the insulin receptor and decreases 
insulin-stimulated tyrosine receptor kinase [ 161. 
Simil~ly, phorbol esters cause insulin receptor 
phosphorylation [ 17- 191 and decrease insulin ac- 
tion in some cells [ 171. The phorbol esters 
stimulate phosphorylation of the insulin and IGF-I 
receptors at sites different from those 
phosphorylated upon ligand binding [ 18,191. Pro- 
tein kinase C directly phosphorylates the insulin 
receptor in vitro, causing a decrease in its tyrosine 
kinase activity [20]. Thus, a counter-regulatory 
relationship may exist between activation of the in- 
sulin and IGF-I receptor kinases and the activity of 
protein kinase C or another unknown protein 
kinase that acts on these receptors. 
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